Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” fourth quarter 2024 investor letter ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow ...

Fintel reports that on March 14, 2025, Stifel upgraded their outlook for Danaher (NYSE:DHR) from Hold to Buy. Analyst Price ...

Why Is Danaher Corporation’s Stock Showing Market Fluctuations?

Shares of Danaher Corp. DHR slipped 3.23% to $205.23 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 2.70% to 5,614.56 and Dow ...

AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...

The Rising Need for Efficient and Effective Drug Discoveries Worldwide is Expected to Create Lucrative Growth Opportunities in the Market.

AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...

The latest research report published by Vantage Market Research, titled "An Increase in Demand and Opportunities for the ...

The global Dental Implants and Prosthetics Market, valued at US$11.61 billion in 2024, is forecasted to grow at a robust CAGR ...